Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO)

Industry: Medical - Diagnostics & Research Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $273.20 — $390.99
Selected (Average) $318.81
Upside to Live -48.47%
Full Range Fair Value
Range (Low - High) $284.22 — $437.95
Selected (Average) $341.66
Upside to Live -44.78%
Live Price $618.72

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
TMO 1 Thermo Fisher Scie 43,736 26.71 25.17 18.46 17.31 26.91 24.85
DHR 2 Danaher Corporatio 24,268 37.50 36.90 21.37 20.55 31.78 25.17
0QNO.L 3 Lonza Group AG 17,336 30.36 21.83 12.02 8.64 17.57 13.17
IQV 4 IQVIA Holdings Inc 15,904 25.20 16.94 13.31 11.89 20.66 16.33
SHL.AX 5 Sonic Healthcare L 12,270 12.59 11.77 5.99 5.16 2.85 2.78
ESF.VI 6 Eurofins Scientifi 12,203 21.20 21.20 7.66 7.66 5.39 9.29
DGX 7 Quest Diagnostics 10,850 22.03 22.60 12.77 12.56 17.68 17.85
IDHC.L 8 Integrated Diagnos 9,048 9.06 7.63 4.99 4.14 5.49 4.96
A 9 Agilent Technologi 6,948 31.79 28.22 23.43 21.62 24.26 25.99
603259.SS 10 WuXi AppTec Co., L 5,887 14.18 10.09 9.76 6.93 8.03 6.90
SYNH 11 Syneos Health, Inc 5,419 61.34 61.34 14.50 14.37 42.53 24.71
ILMN 12 Illumina, Inc. 4,287 20.39 19.99 12.25 11.75 17.16 19.07
IDXX 13 IDEXX Laboratories 4,167 49.81 43.08 35.28 30.68 36.09 33.84
CRL 14 Charles River Labo 4,024 - - 19.32 20.43 18.64 87.76
WAT 15 Waters Corporation 3,106 26.76 25.45 17.61 16.47 23.93 21.06
EXAS 16 Exact Sciences Cor 3,082 - - - - - -

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple22.0321.2012.5111.8217.6217.09
Full Range Median Multiple25.2021.8313.0412.2218.1618.46
Industry Multiple27.8625.1615.0213.7719.4322.06
Market Implied Multiple35.6033.5423.6122.1434.4331.79
Company (TMO) Multiple26.7125.1718.4617.3126.9124.85
(*) Net Income / EBITDA / Revenue6,5706,97311,33212,0847,7728,417
Winsorized Enterprise ValueN/AN/A141,718142,806136,969143,846
Full Range Median Enterprise ValueN/AN/A147,723147,694141,132155,359
(-) Net Debt33,69833,69833,69833,69833,69833,698
Winsorized Equity Value144,723147,795108,020109,108103,271110,148
Full Range Median Equity Value165,544152,225114,025113,996107,434121,661
(/) Shares Outstanding378378378378378378
Winsorized Fair Value$382.86$390.99$285.77$288.65$273.20$291.40
Full Range Median Fair Value$437.95$402.71$301.65$301.58$284.22$321.86
Current Price$618.72$618.72$618.72$618.72$618.72$618.72
Upside / Downside-38.12%-36.81%-53.81%-53.35%-55.84%-52.90%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$268.01$273.70$200.04$202.05$191.24$203.98
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy